Literature DB >> 22343871

A study in scarlet-convalescent plasma for severe influenza*.

John H Beigel, Thomas C Luke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22343871      PMCID： PMC3287074          DOI： 10.1097/CCM.0b013e31823d77c3

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  13 in total

Review 1.  Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

Authors:  Edgar Bautista; Tawee Chotpitayasunondh; Zhancheng Gao; Scott A Harper; Michael Shaw; Timothy M Uyeki; Sherif R Zaki; Frederick G Hayden; David S Hui; Joel D Kettner; Anand Kumar; Matthew Lim; Nahoko Shindo; Charles Penn; Karl G Nicholson
Journal:  N Engl J Med       Date:  2010-05-06       Impact factor: 91.245

2.  Avian influenza: exploring all the avenues.

Authors:  John J Treanor
Journal:  Ann Intern Med       Date:  2006-08-29       Impact factor: 25.391

3.  Treatment with convalescent plasma for influenza A (H5N1) infection.

Authors:  Boping Zhou; Nanshan Zhong; Yi Guan
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

4.  Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States--September-October 2009.

Authors:  Jacek Skarbinski; Seema Jain; Anna Bramley; Esther J Lee; Jean Huang; David Kirschke; Allison Stone; Tiffany Wedlake; Shawn M Richards; Shannon Page; Patti Ragan; Lesley Bullion; Daniel Neises; Robin M Williams; Bruno P Petruccelli; Meredith Vandermeer; Kathryn H Lofy; Jacqueline Gindler; Lyn Finelli
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

5.  Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry.

Authors:  Wiku Adisasmito; Paul K S Chan; Nelson Lee; Ahmet Faik Oner; Viktor Gasimov; Faik Aghayev; Mukhtiar Zaman; Ebun Bamgboye; Nazim Dogan; Richard Coker; Kathryn Starzyk; Nancy A Dreyer; Stephen Toovey
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

6.  Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

Authors:  Tiffany G Sheu; Alicia M Fry; Rebecca J Garten; Varough M Deyde; Thein Shwe; Lesley Bullion; Patrick J Peebles; Yan Li; Alexander I Klimov; Larisa V Gubareva
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

Review 7.  Hark back: passive immunotherapy for influenza and other serious infections.

Authors:  Thomas C Luke; Arturo Casadevall; Stanley J Watowich; Stephen L Hoffman; John H Beigel; Timothy H Burgess
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

8.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

Authors:  Anand Kumar; Ryan Zarychanski; Ruxandra Pinto; Deborah J Cook; John Marshall; Jacques Lacroix; Tom Stelfox; Sean Bagshaw; Karen Choong; Francois Lamontagne; Alexis F Turgeon; Stephen Lapinsky; Stéphane P Ahern; Orla Smith; Faisal Siddiqui; Philippe Jouvet; Kosar Khwaja; Lauralyn McIntyre; Kusum Menon; Jamie Hutchison; David Hornstein; Ari Joffe; Francois Lauzier; Jeffrey Singh; Tim Karachi; Kim Wiebe; Kendiss Olafson; Clare Ramsey; Sat Sharma; Peter Dodek; Maureen Meade; Richard Hall; Robert A Fowler
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

9.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

Authors:  Allison McGeer; Karen A Green; Agron Plevneshi; Altynay Shigayeva; Nilofar Siddiqi; Janet Raboud; Donald E Low
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

10.  Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus.

Authors:  Elena A Govorkova; Natalia A Ilyushina; David A Boltz; Alan Douglas; Neziha Yilmaz; Robert G Webster
Journal:  Antimicrob Agents Chemother       Date:  2007-02-12       Impact factor: 5.191
View more
  5 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

Review 2.  Passive broad-spectrum influenza immunoprophylaxis.

Authors:  Cassandra M Berry; William J Penhale; Mark Y Sangster
Journal:  Influenza Res Treat       Date:  2014-09-22

Review 3.  Convalescent plasma: possible therapy for novel coronavirus disease 2019.

Authors:  Huiling Cao; Yuan Shi
Journal:  Transfusion       Date:  2020-05-02       Impact factor: 3.157

Review 4.  Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.

Authors:  Nandeeta Samad; Temitayo Eniola Sodunke; Hasan Al Banna; Ashmita Sapkota; Aneeka Nawar Fatema; Katia Iskandar; Dilshad Jahan; Timothy Craig Hardcastle; Tanzina Nusrat; Tajkera Sultana Chowdhury; Mainul Haque
Journal:  Risk Manag Healthc Policy       Date:  2020-11-23

Review 5.  Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.

Authors:  O Garraud; F Heshmati; B Pozzetto; F Lefrere; R Girot; A Saillol; S Laperche
Journal:  Transfus Clin Biol       Date:  2016-01-06       Impact factor: 1.406
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.